Caprock Group, Inc. Acadia Pharmaceuticals Inc Transaction History

Caprock Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 29, 2021	SELL	$25.02 - $54.99 $105,259 - $231,342	-4,207 Closed	0 $0
Q4 2020 Jan 29, 2021	BUY	$41.04 - $56.79 $172,655 - $238,915	4,207 New	4,207 $225,000
Q3 2020 Oct 29, 2020	SELL	$36.42 - $57.0 $151,033 - $236,379	-4,147 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$39.26 - $52.73 $162,811 - $218,671	4,147 New	4,147 $201,000

288

161M

723K

257K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.54B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Caprock Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Caprock Group, Inc. with notifications on news.